Brief: Chemomab Therapeutics Announces Q1 2023 Financial Results, Provides A Corporate Update
11/05/2023 11:28
May 11 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
* CHEMOMAB THERAPEUTICS LTD - EXTENDING ESTIMATED CASH
RUNWAY
THROUGH FIRST HALF OF 2024
* CHEMOMAB THERAPEUTICS LTD - NET LOSS OF ABOUT $0.04 PER
ORDINARY
SHARE FOR Q1
Source text for Eikon: ID:nPn1jhnZpa
Further company coverage: CMMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update